Analysts have shared a variety of opinions on Sotera Health (NASDAQ: SHC) over the past three months. The latest ratings from four analysts reveal a range of sentiments, with four analysts showing some optimism towards the company. One analyst gave a somewhat bullish rating in the last 30 days, while two analysts were somewhat bullish a month ago. The average 12-month price target for Sotera Health is $19.0, with a high estimate of $20.00 and a low estimate of $17.00, indicating an 18.75% increase from the previous average price target of $16.00.
Taking a closer look at analyst actions, Sean Dodge from RBC Capital maintained an “Outperform” rating with a price target of $20.00. Luke Sergott from Barclays upgraded the rating to “Overweight” with a current price target of $19.00, up from the previous target of $17.00.
In the current month, Sotera Health has received five Buy Ratings, two Hold Ratings, and no Sell Ratings. The consensus rating is Strong Buy, based on three buy ratings and one hold rating. The average price target for Sotera Health is $19.33, suggesting a 39.77% upside potential from the current price.
SHC Stock Shows Positive Momentum Near Bottom of 52-Week Range
On March 11, 2024, SHC stock showed some positive momentum as it traded near the bottom of its 52-week range and below its 200-day simple moving average. The price of SHC shares increased by $0.13 since the market last closed, representing a 0.94% rise. Despite opening at $13.72, which was $0.11 lower than its previous close, SHC was able to make gains throughout the trading day, showing resilience and potential for growth. Trading near the bottom of its 52-week range suggests that SHC may be undervalued, making it an attractive opportunity for investors looking for potential upside. Additionally, being below its 200-day simple moving average indicates that the stock may have room to climb higher in the future. Investors should keep an eye on SHC as it continues to show positive price momentum and potential for further growth. Conduct thorough research and analysis before making any investment decisions.
SHC Stock Shows Strong Financial Performance with Revenue and Net Income Growth
On March 11, 2024, SHC stock had a strong performance based on the financial data provided by CNN Money. The company reported a total revenue of $1.05 billion for the past year, which represented a 4.54% increase compared to the previous year. Additionally, the total revenue for the last quarter was $310.24 million, showing a significant increase of 17.88% compared to the previous quarter.
In terms of net income, SHC reported a net income of $51.09 million for the past year, marking a substantial increase of 121.87% compared to the previous year. The net income for the last quarter was $38.47 million, which represented an impressive increase of 381.61% compared to the previous quarter.
Furthermore, the earnings per share (EPS) for SHC were reported at $0.18 for the past year and $0.14 for the last quarter. The EPS increased by 121.63% compared to the previous year and by 379.42% compared to the previous quarter.
Overall, SHC’s strong financial performance on March 11, 2024, demonstrated significant growth in total revenue, net income, and earnings per share. Investors may view these positive financial indicators as a sign of the company’s strong performance and potential for future growth.
